Conversations around savings used to feel intrusive for 340B covered entities. However, times are changing. Today, many covered entities are more transparent than ever, offering detailed reports on how their dollars are being allocated. Visante’s Managing Director, Kristin Fox-Smith, has observed a remarkable shift, noting an increased willingness to share how these important funds are being utilized. Kristin and Ted Slafsky, CEO of 340B Report, recently discussed this issue on Visante’s Pharmacy Innovators Podcast. Enjoy the full podcast here.
- The BUZZ / News
- Publications
- MarketplaceAutomationCompoundingContamination ControlDelivery & ShippingDistributionFacilitiesFinanceManufacturingMerchandisingPatient CareHighlighted Practice SettingsProfessional DevelopmentProfessional ServicesSoftware
- Business Management, Operations, ERP
- Clinical Monitoring, Surveillance, Insights
- Controlled Substance Reporting
- Clinical Decision Support, Point of Care Reference, Dosing, DUR
- Drug Diversion Monitoring, Diversion Prevention
- Error Prevention, Drug Validation
- eMAR, EMR, EHR, Bedside Verification
- Formulary Management
- IV Workflow Management
- Long-Term Care Operation Management
- Medication Inventory Management & Procurement
- Pharmacy Management Systems, Workflow
- Stewardship Resources (Antibiotic, Opioid, etc)
Unit DoseWorkflow - Multimedia Content
- Career Center
- Market Intelligence
- Company
